Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The P-VALUE-AHF trial is a multicenter, randomized, open-label, parallel-group trial on the
diuretic and decongestive effects of different diuretic escalation strategies in patients
with acute heart failure and diuretic resistance.
The main aims are
- to compare the diuretic efficacy of three therapeutic strategies in patients with acute
heart failure and diuretic resistance.
- to assess the improvement in clinical congestion and to compare the symptom-relief among
the different treatment regimens